Genome Web Breaking News
- FDA Approves Qiagen's PIK3CA Test as Companion Test for Novartis Breast Cancer Drug
- People in the News: Nelson Chan, David Fenstermacher, Sangeeta Bhorade
- Local Coverage Determinations Roundup: Natera, Guardant Health, Transplant Genomics, and More
- In Brief This Week: Personalis, Todos Medical, Invivoscribe, and More
- Arev Brands International, Lighthouse Genomics Ink Cannabis Genotyping Agreement
Stat
- Teva reaches $85 million settlement on eve of opioid trial in Oklahoma
- STAT Plus: Pharma donates big bucks to U.K. patient groups, but transparency found lacking
- At $2.1 million, newly approved Novartis gene therapy will be world’s most expensive drug
- STAT Plus: FTC says pay-to-delay cases fell, prompting trade group to argue legislation isn’t needed
- Former NFL players die at a faster rate than other professional athletes, study finds
NYT science news
- In Russia’s Provinces, the Doctor Is in (the Streets)
- E.P.A. Experts Objected to ‘Misleading’ Agency Smog Decision, Emails Show
- Older People Are Contributing to Climate Change, and Suffering From It
- Murray Gell-Mann, Who Peered at Particles and Saw the Universe, Dies at 89
- This New Treatment Could Save the Lives of Babies. But It Costs $2.1 Million.
Xconomy news
- Stoke Therapeutics Preps IPO to Bring Dravet Syndrome Drug to Clinic
- Inhibrix Pulls In $40M to Press Ahead With Cancer Drug Clinical Trials
- Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M
- Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More
- Nektar Forms New Company Inheris to Take Reins on Pain, CNS Drugs
Fierce Biotech
- Novocure nets approval for its Tumor Treating Fields therapy in mesothelioma
- FLX Bio keeps it capital in RAPT Therapeutics rebrand
- Stoke files for $86M IPO to take Dravet drug from preclinical to phase 3
- Dynavax axes immuno-oncology pipeline and 82 staff
- Cala Health secures $50M to market its tremor-treating wearable
Fierce Medical Devices
- Novocure nets approval for its Tumor Treating Fields therapy in mesothelioma
- Cala Health secures $50M to market its tremor-treating wearable
- Roche, Hologic, Cepheid nab separate FDA clearances for new STI tests
- That was fast: Ex-FDA commish goes back to biotech investing
- Google’s cancer-spotting AI outperforms radiologists in reading lung CT scans